Research - News
The results will demonstrate where the novel coronavirus has spread undetected in the United States and provide insights into the types of populations that are most affected.
AMPLIFY and DUET provide sound information and support to make changes in diet and physical activity that are key in keeping cancer survivors and their loved ones healthy.
UAB moved its premiere undergraduate research event online during the pandemic.
Mieke Beth Thomeer, Ph.D., and Jenjira Yahirun, Ph.D., discuss how families influence health and health disparities throughout life’s course and during COVID-19.
While demand for medical cannabis products grows in the United States, a UAB study suggests health care providers are ill-equipped to provide guidance.
The complement system is part of the body’s immune system to fight pathogens and remove cell debris. Its role in two autoimmune diseases and a mental disorder is a surprise.
A new rapid sexually transmitted infection test developed through research done at UAB will help diagnose and treat patients in real time moving forward.
Dual antiplatelet therapy after percutaneous coronary intervention uses aspirin and one other drug, among several choices. But which drug is best to use?
This discovery may have clinical importance in management of heart failure.
Amid the ongoing coronavirus pandemic, UAB students developed a project to help inform the Birmingham community and beyond.
A study conducted by UAB investigators has outlined the importance of strict blood pressure control in the development of atrial fibrillation, which can lead to poor outcomes such as stroke, heart attacks and death.
A microbiome “fingerprint” method allows tracking of mothers’ microbial strains inherited by infants.
This is thought to be the first time that information found via artificial intelligence has led to a clinical trial.
A partnership among UAB’s emergency department, School of Health Professions and community health providers will use telemedicine to reach patients in rural counties with opioid use disorder.
The research is led by an Oregon cancer research institute, in collaboration with two biotech companies and the National Institutes of Health.
UAB’s School of Engineering continues to move forward with development of personal protective equipment.
Gender identity and genetic sex are distinctly variable when it comes to pain tolerance, according to a study published in the Journal of Pain Research.
Model building and analysis of optically controlled quantum computation at UAB leads to new discovery.
UAB researchers have quickly developed and launched multiple research studies geared at treating or preventing COVID-19, following generous funding support from the Birmingham community.
UAB Department of Cell, Developmental and Integrative Biology ranks fourth in nation for NIH funding
The ranking measured 79 anatomy/cell biology departments in U.S. medical schools.
The work centers around ReFRAME, a vast collection of drugs developed for other diseases that are already known to be safe for humans.
Such competitive awards demonstrate that UAB provides students “an exceptionally strong foundation for research success.”
The goal is material that approaches a diamond in hardness and can survive extreme pressure, temperature and corrosive environments.
UAB’s School of Engineering produces face shield prototype to assist with PPE shortage due to the coronavirus.
A UAB School of Optometry professor has received an R01 grant from the NIH to study age-related cataracts, with hopes to slow their progression.
UAB Biomedical Engineering brings in more NIH funding do than regional peers like Vanderbilt, Duke and others, according to data from the Blue Ridge Institute.
iNO has been used for the treatment of failing lungs, but it was also found to have antiviral properties against coronaviruses.
UAB expert Gary Warner and UAB Information Technology provide tips on how to protect yourself from cybercrime during the coronavirus pandemic.
This discovery has implications in cancer, stem cell growth, and blood or neuron progenitor cell speciation.
The testing at UAB will investigate immune responses to the vaccine in mice — an important step before any Phase 1 human safety trial in patients later this year.